US 11,299,760 B2
USE OF MONENSIN TO REGULATE GLYCOSYLATION OF RECOMBINANT PROTEINSGeneral
US 11,299,760 B2
USE OF MONENSIN TO REGULATE GLYCOSYLATION OF RECOMBINANT PROTEINS
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Michail A Belyavskyi
Art Unit:
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
Agent:
Henry P. Wu
Inventors:
Mirna MUJACIC; Sandhya PANDE
Assignee:
Priority:
10/30/14
Filed:
09/01/21
Granted:
04/12/22
Expiration:
10/31/33
Cooperative Patent Classification (CPC)
C12C12P21/005C12P